Denali Therapeutics Inc. (DNLI)

NASDAQ: DNLI · Real-Time Price · USD

14.80

+0.43 (2.99%)

At close: May 12, 2025, 4:00 PM

14.70

-0.10 (-0.68%)

After-hours: May 12, 2025, 6:18 PM EDT

Denali Therapeutics Market Cap

Denali Therapeutics has a market cap or net worth of $2.15 billion as of May 12, 2025. Its market cap has decreased by -3.06% in one year.

Market Cap

2.15B

Enterprise Value

1.15B

1-Year Change

-3.06%

Ranking

#1852

Market Cap Chart

Since December 8, 2017, Denali Therapeutics's market cap has increased from $1.89B to $2.15B, an increase of 13.93%. That is a compound annual growth rate of 1.77%.

Market Cap History

Date	Market Cap	% Change
May 9, 2025	2.09B	-28.83%
Dec 31, 2024	2.93B	-1.10%
Dec 29, 2023	2.97B	-21.48%
Dec 30, 2022	3.78B	-30.66%
Dec 31, 2021	5.45B	-45.77%
Dec 31, 2020	10.04B	500.43%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	659.45B
Johnson & Johnson	371.06B
UnitedHealth Group	345.29B
AbbVie	326.55B
Novo Nordisk	297.79B
Abbott Laboratories	231.82B
Novartis AG	214.71B
AstraZeneca	211.14B

Market Cap Rankings